Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial Hypertension

Ventavis is an inhaled formulation of iloprost, a prostacyclin analog, indicated for the treatment of pulmonary arterial hypertension (PAH) in patients with NYHA Class III or IV symptoms.

Posted: December 2004

Related Articles:

Ventavis (iloprost) FDA Approval History

View comments

Hide
(web5)